Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
Cytokine|May 14, 2013
CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patientsDina Ragab, Melissa Laird, Darragh Duffy, et al.
Digestive Diseases (Basel, Switzerland)|July 7, 2026
Consensus recommendations for the management of H. pylori in Egypt: 2026 reportMohamed Alboraie, Walied Elhossary, Sherief Abdel-Salam, et al.
Expert Review of Gastroenterology & Hepatology|May 15, 2018
An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimensMohamed El Kassas, Mohamed Alboraie, Dalia Omran, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 5, 2017
Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian ExperienceTamer Elbaz, Magdy Elserafy, Wafaa Elakel, et al.
Expert Review of Gastroenterology & Hepatology|June 8, 2019
High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter studySamar K Darweesh, Kadry Elsaeed, Heba Omar, et al.
Journal of Gastroenterology and Hepatology|December 25, 2010
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapyMostafa K El Awady, Mohamed A Anany, Gamal Esmat, et al.
Gut|April 19, 2018
Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in EgyptGamal Shiha, Gamal Esmat, Mohamed Hassany, et al.
Expert Review of Anti-Infective Therapy|July 6, 2021
Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian studyMahmoud El-Bendary, Sherief Abd-Elsalam, Tamer Elbaz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 21, 2019
Sofosbuvir-containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairmentRasha Eletreby, Magdy El-Serafy, Mahmoud Anees, et al.
Journal of Hepatology|September 23, 2017
Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4Gamal Esmat, Tamer Elbaz, Maissa El Raziky, et al.
Pageof 22